FIRDAPSE cpr 10 mg 100 pce

7680618530019 CH-61853 N07XX05 01.14.0.
FIRDAPSE cpr 10 mg 100 pce
FIRDAPSE cpr 10 mg 100 pce
FIRDAPSE cpr 10 mg 100 pce
1 / 3
google

Details

Product number
6185301
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
amifampridinum 10 mg ut amifampridini phosphas, cellulosum microcristallinum, silica colloidalis anhydrica, calcii stearas, pro compresso.

Articles (1)

Firdapse, Tabletten
Tabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
30/05/2022
Professional SmPC
Français
30/05/2022
Professional SmPC
Italien
30/05/2022
Patient information leaflet
Allemand
16/05/2022
Patient information leaflet
Français
16/05/2022
Patient information leaflet
Italien
16/05/2022

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1567.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2025

Authorization holder

DRAC AG

3280 Murten

Authorization information

Swissmedic authorization number
61853
Drug name
Firdapse, Tabletten
Galenic form
TAB
ATC Code
N07XX05
Authorization status
Z
Dispensation category
B
First authorization
22/08/2012
Authorization expiration date
31/12/9999
IT number
01.14.0.
Domain
Human medicine
Field of application
Symptomatische Behandlung des Lambert-Eaton-Myasthenie Syndroms (LEMS) bei Erwachsenen

Packaging details

Description (FR)
FIRDAPSE cpr 10 mg 100 pce
Description (DE)
FIRDAPSE Tabl 10 mg 100 Stk
Market launch
22/08/2012
Narcotic (BTM)
No